A functional screen of the epigenome identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers
Zainab Jagani,Gregory Hoffman,Rami Rahal,Frank Buxton,Gregory McAllister,Kay Xiang,Elizabeth Frias,Janina Huber,Alicia Lindeman,Dongshu Chen,Linda Bagdasarian,Rodrigo Romero,Nadire Ramadan,Tanushree Phadke,Kristy Haas,Mariela Jaskelioff, Boris Wilson,Matthew Meyer,Margaret E. McLaughlin,Charles W. M. Roberts,Vic Myer,Jeff Porter,Nicholas Keen,Craig Mickanin,Frank Stegmeier MOLECULAR CANCER THERAPEUTICS（2013）
AI 理解论文
溯源树
样例
